| Financial Year |
September 30 2022 |
| Monetary Funds |
94,968,577.98 |
| Held-for-trading Financial Assets |
500,000.00 |
| Notes Receivable |
7,828,982.66 |
| Accounts Receivable |
137,849,071.10 |
| Advances to Suppliers |
21,779,262.07 |
| Other Receivables |
1,613,942,053.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
607,608,362.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,720,870.35 |
| Total Current Assets |
2,567,939,086.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
182,038,624.91 |
| Investment Properties |
290,094,551.37 |
| Fixed Assetes |
607,085,732.87 |
| Under-construction Projects |
31,796,028.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
68,205,544.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
69,051.20 |
| Deferred Income Tax Assets |
11,651,372.91 |
| Other Non-Current Assets |
11,117,708.91 |
| Sub-Total of Non-Current Assets |
1,238,259,430.51 |
| Total Assets |
3,806,198,517.26 |
| Short-Term Loans |
1,029,634,038.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
500,250,751.65 |
| Accounts Received In Advance |
1,868,869.32 |
| Employee Compensation Payable |
16,823,302.06 |
| Taxes Payable |
958,056,571.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
411,189,570.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
261,310,610.01 |
| Other Current Liabilities |
156,849,764.55 |
| Sub-Total of Current Liabilities |
4,493,120,293.09 |
| Long-term Loans |
264,741,935.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,166,358,278.99 |
| Deferred Income Tax Liabilities |
7,288,607.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,438,538,822.37 |
| Total Liabilities |
5,931,659,115.46 |
| Paid-In Capital(Or Share Stock) |
994,886,058.00 |
| Capital Surplus |
1,838,363,648.23 |
| Surplus Reserve |
644,949,277.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,573,148,330.19 |
| Minority Stockholder's Interest |
-13,022,984.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,112,437,613.62 |
| Owner's Equity（Stockholder's Equity） |
-2,125,460,598.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,806,198,517.26 |
